About 29,400 results
Open links in new tab
  1. Masimo - Home

    Mar 23, 2011 · Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide …

  2. Masimo - Home

    Learn how to use the Masimo SafetyNet monitoring system, including setting up the mobile app and applying a sensor, with simple instructions and videos

  3. Masimo - Wikipedia

    Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive …

  4. Danaher To Acquire Masimo Corporation - Feb 17, 2026

    Feb 17, 2026 · Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation …

  5. Masimo - Masimo SET®: Clinically Proven

    The accuracy and reliability of Masimo SET® pulse oximetry has been studied in challenging conditions. Masimo SET® pulse oximeters detected approximately 10 times more true events than other “Next …

  6. Masimo - LinkedIn

    Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors ...

  7. Danaher Buys Masimo: Irvine Health Tech Firm Sold for $9.9B - Los ...

    Mar 11, 2026 · Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation …

  8. Masimo - YouTube

    Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors,...

  9. Danaher to buy Masimo in $9.9 billion deal in diagnostics push - CNBC

    Feb 17, 2026 · Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher …

  10. What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive

    Sep 30, 2024 · What’s next at Masimo after CEO Kiani’s exit? Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation …